These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32391613)

  • 1. Targeting telomerase for its advent in cancer therapeutics.
    Bajaj S; Kumar MS; Peters GJ; Mayur YC
    Med Res Rev; 2020 Sep; 40(5):1871-1919. PubMed ID: 32391613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
    Ganesan K; Xu B
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Telomerase inhibition, telomere attrition and proliferation arrest of cancer cells induced by phosphorothioate ASO-NLS conjugates targeting hTERC and siRNAs targeting hTERT.
    Diala I; Shiohama Y; Fujita T; Kotake Y; Demonacos C; Krstic-Demonacos M; Leva GD; Fujii M
    Nucleosides Nucleotides Nucleic Acids; 2020; 39(1-3):407-425. PubMed ID: 32310030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ectopic expression of human telomerase RNA component results in increased telomerase activity and elongated telomeres in bovine blastocysts.
    Garrels W; Kues WB; Herrmann D; Holler S; Baulain U; Niemann H
    Biol Reprod; 2012 Oct; 87(4):95. PubMed ID: 22855562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raising the bar in anticancer therapy: recent advances in, and perspectives on, telomerase inhibitors.
    Saraswati AP; Relitti N; Brindisi M; Gemma S; Zisterer D; Butini S; Campiani G
    Drug Discov Today; 2019 Jul; 24(7):1370-1388. PubMed ID: 31136800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Telomerase reverse transcriptase in the regulation of gene expression.
    Zhou J; Ding D; Wang M; Cong YS
    BMB Rep; 2014 Jan; 47(1):8-14. PubMed ID: 24388106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1,3,4-Oxadiazoles as Telomerase Inhibitor: Potential Anticancer Agents.
    Bajaj S; Roy PP; Singh J
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1869-1883. PubMed ID: 28443517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential Telomere-Related Pharmacological Targets.
    Berei J; Eckburg A; Miliavski E; Anderson AD; Miller RJ; Dein J; Giuffre AM; Tang D; Deb S; Racherla KS; Patel M; Vela MS; Puri N
    Curr Top Med Chem; 2020; 20(6):458-484. PubMed ID: 31916516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
    Chen R; Zhu J; Dong Y; He C; Hu X
    Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild hyperoxia limits hTR levels, telomerase activity, and telomere length maintenance in hTERT-transduced bone marrow endothelial cells.
    Napier CE; Veas LA; Kan CY; Taylor LM; Yuan J; Wen VW; James A; O'Brien TA; Lock RB; MacKenzie KL
    Biochim Biophys Acta; 2010 Oct; 1803(10):1142-53. PubMed ID: 20619302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA Methylation Profiling of hTERT Gene Alongside with the Telomere Performance in Gastric Adenocarcinoma.
    Vahidi S; Norollahi SE; Agah S; Samadani AA
    J Gastrointest Cancer; 2020 Sep; 51(3):788-799. PubMed ID: 32617831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to inhibit telomerase activity for cancer therapy.
    Kyo S; Inoue M
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):613-26. PubMed ID: 12678728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human telomerase reverse transcriptase mediates the senescence of mesenchymal stem cells through the PI3K/AKT signaling pathway.
    Zhao Q; Wang XY; Yu XX; Zhai YX; He X; Wu S; Shi YA
    Int J Mol Med; 2015 Sep; 36(3):857-64. PubMed ID: 26178664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.
    Babizhayev MA; Yegorov YE
    J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Telomere shortening and cell senescence induced by perylene derivatives in A549 human lung cancer cells.
    Taka T; Huang L; Wongnoppavich A; Tam-Chang SW; Lee TR; Tuntiwechapikul W
    Bioorg Med Chem; 2013 Feb; 21(4):883-90. PubMed ID: 23321015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Telomerase activity, TERT expression, hTERT promoter alterations, and alternative lengthening of the telomeres (ALT) in meningiomas - a systematic review.
    Stögbauer L; Stummer W; Senner V; Brokinkel B
    Neurosurg Rev; 2020 Jun; 43(3):903-910. PubMed ID: 30788677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting human telomerase in cancer therapy.
    Huard S; Autexier C
    Curr Med Chem Anticancer Agents; 2002 Sep; 2(5):577-87. PubMed ID: 12678725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere and Telomerase Therapeutics in Cancer.
    Xu Y; Goldkorn A
    Genes (Basel); 2016 May; 7(6):. PubMed ID: 27240403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase expression and cell proliferation in ovarian cancer cells induced by histone deacetylase inhibitors.
    Zhu K; Qu D; Sakamoto T; Fukasawa I; Hayashi M; Inaba N
    Arch Gynecol Obstet; 2008 Jan; 277(1):15-9. PubMed ID: 17680259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.